US-based sciences company Cytiva has opened a new manufacturing facility and Experience Centre in Pune, India. The facility will double Cytiva s manufacturing capacity in India and offer training programmes to accelerate the development of novel therapeutics. The facility will produce bioprocessing equipment, while the Experience Centre will provide immersive training programmes on various technologies. Cytiva s move is in response to the rising demand for biologic medicines in India, with 65% of biopharma executives expecting a significant increase in biologics manufacturing in the next three years.
Back in May, Cytiva completed its integration with Pall Life Sciences, a move that CEO Emmanuel Ligner now describes as a “winning recipe” which has improved the company’s supply chain and fostered industry collaboration.
/PRNewswire/ Cytiva and the life sciences business of Pall Corporation have completed their integration and are now united as one business under the Cytiva.
Cytiva and the life sciences business of Pall Corporation are now united as one business under the Cytiva brand, with the completion of the integration announced this morning. Emmanuel Ligner, Danaher Group Executive, President and CEO of Cytiva, tells us how the company will focus its efforts moving forward to support long-term growth of the biotech industry.